GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 09/23 11:36:50 am
1414GBX -1.05%

GlaxoSmithKline : Gsk Announces FDA Approval For Nucala For Use In Adults With Chronic Rhinosinusitis With Nasal Polyps

07/29/2021 | 02:16pm

July 29 (Reuters) - GlaxoSmithKline PLC:

* GSK ANNOUNCES FDA APPROVAL FOR NUCALA (MEPOLIZUMAB) FOR USE IN ADULTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS Further company coverage:

© Reuters 2021
Copier lien
All news about GLAXOSMITHKLINE PLC
4h ago
12h ago
15h ago
16h ago
1d ago